Planet DDS 2026 Dental Outlook Shows More New Patients, Fewer No-Shows Across the Industry Planet DDS, a leading provider of cloud-based, enterprise-grade dental software solutions, announced the release of its 2026…
Parabilis Medicines’ Zolucatetide, the First and Only Direct Inhibitor of the Elusive β-catenin:TCF Interaction, Receives FDA Orphan Drug Designation for the Treatment of Desmoid Tumors Parabilis Medicines, a clinical-stage biopharmaceutical…
Lyra Health Joins Workday Wellness Program as Preferred Mental Health Partner Lyra Health, the leader in workforce mental health solutions, announced that it has been named the Workday Wellness Preferred…
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C GeneDx the leader in rare disease diagnosis and improving health through the…
InterSystems Appoints Former NHS and Mass General Leader Dr. Tim Ferris as Vice President, Healthcare Practice InterSystems, a creative data technology provider powering more than one billion health records globally,…
Innovaccer Launches Flow Capture, Bringing Autonomous Coding to the Frontlines of American Healthcare Innovaccer, the leading healthcare AI company, launched Flow Capture, an autonomous medical coding solution designed to eliminate…
NRC Health Announces $60 Million Share Repurchase Authorization National Research Corporation, doing business as NRC Health, has announced that its Board of Directors has approved a new stock repurchase program…
Anthem, Athens Orthopedic Clinic Partner to Expand Orthopedic Access in Northeast Georgia Anthem Blue Cross and Blue Shield of Georgia has entered into a strategic partnership with Athens Orthopedic Clinic…
GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen® GoodRx the leading platform for prescription savings in the U.S., today announced employer-sponsored access to Zepbound® (tirzepatide) KwikPen® (for single-patient-use) through GoodRx Employer Direct.…
FDA Greenlights Sotyktu to Treat Active Psoriatic Arthritis in Adults The U.S. Food and Drug Administration (FDA) has approved Sotyktu (deucravacitinib), developed by Bristol Myers Squibb, for the treatment of…
Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results Silence Therapeutics plc, a global clinical-stage company developing novel siRNA (short interfering RNA) therapies,…
Lucidis® Sets High Standards in Premium Cataract Surgery with Full-Range Vision Performance Swiss Advanced Vision announces new clinical evidence confirming the exceptional performance of its Lucidis® intraocular lens (IOL), strengthening…